Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology
NSE:MEDICAPQ

MEDI CAPS LTD.

Healthcare › Pharmaceuticals & Biotechnology
₹25.50
at close · 9 Oct 2026
▲ 0.50 (+2.00%)

Latest filings

  1. Quarterly compliance certificate for dematerialization of securities · Compliance
  2. Trading window closed from Oct 1 ahead of Q2 results · Compliance
  3. AGM approves CMD re-appointment and new Woman Director · Board & Shareholder Meetings
All filings ↓
Ask Nexa about MEDI CAPS LTD.

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹12 Cr over the trailing twelve months.

Market Cap
₹31 Cr
P / E (TTM)
—
EV / EBITDA
—
Div Yield
—
Growth
-26.7%▼
Revenue 5y CAGR
PAT — · EBITDA —
Quality
-0.7%·
ROCE (5y median)
ROE -0.5% (5y median) · margin -9.7%
Leverage
0.00·
Debt / Equity · low
Net cash ₹0.50 Cr
Revenue FY21→FY26
0.2×▼
Margin −43.4 pts
₹59 Cr → ₹12 Cr
Cash conversion
0.99×·
Operating cash ÷ profit · 5 yrs
₹6 Cr on ₹6 Cr
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/B#3/163
ROCE#159/183
ROE#147/166
Debt / Equity#1/166
EBITDA margin#3/165
Revenue growth#154/161
Profit growth#46/158

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
No borrowings on the balance sheet
lower than 79% of its 166 Pharmaceuticals peers
Concerns
Revenue shrinking over 5 years (−27% a year)
Erratic profits — up in only 1 of the last 5 years
Negative returns on capital — −0.7% (5-year median)
#159 of 183 in Pharmaceuticals on the latest reported figures · down from 10.6% in FY21
Heavy working capital — 275 days of cash tied up
Customers are taking longer to pay — 40 → 203 days of receivables
FY21 → FY26

Charts

How has the market priced it — with filings on the timeline?

MEDICAPQ · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from MEDI CAPS LTD.'s filed financials and exchange disclosures

What does MEDI CAPS LTD. do?

MEDI CAPS LTD. is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol MEDICAPQ.

Is MEDI CAPS LTD. profitable?

No. Over the trailing twelve months MEDI CAPS LTD. reported a net loss of ₹3.04 Cr on revenue of ₹12 Cr.

Does MEDI CAPS LTD. pay a dividend?

Not in the latest reported year — MEDI CAPS LTD.'s dividend payout for FY26 was nil.

Is MEDI CAPS LTD. debt-free?

Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹0.50 Cr of cash.

Where can I track MEDI CAPS LTD.'s announcements?

Every NSE and BSE filing by MEDI CAPS LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.